Jun 2026
74th ASMS attendance
- Bruker eXceed Symposium participation
- Poster session in co-autoship with Bruker: Unlocking the discriminative potential of MALDI-TOF profiling data with an AI-enabled software solution for biomarker discovery, classification and typing
Apr 2026
36th ESCMID GLOBAL attendance with several scientific contributions
ePoster Flash Sessions:
- Machine learning assisted differentiation of Mycobacterium tuberculosis complex species from MALDITOF mass spectra
- A data-driven framework for Streptococcus pneumoniae serotype prediction from mass spectrometry profiles
Poster Sessions:
- Typing Clostridioides difficile ribotypes using three MALDI-TOF mass spectrometry systems – MALDI Biotyper, Vitek MS PRIME and LEXI-MS – and Machine Learning classification Models
- Integrating MALDI-TOF spectra and machine learning for accurate classification of Mycobacterium abscessus subspecies
- Spectral variability analysis for typing of Clostridioides difficile using MALDI-TOF mass spectrometry and Machine Learning
- MALDI-TOF mass spectrometry coupled with Machine Learning for rapid detection of four major High-Risk Clones of Pseudomonas aeruginosa
Jan 2026
Marketing partnership with Bruker® Daltonics
Marketing agreement between Bruker® Daltonics and Clover Biosoft for the promotion of using Clover MSDAS for Bruker’s MALDI instruments
Apr 2025
35th ECCMID Attendance
Clover was featured in two oral sessions:
🔹 Laurent Dortet presented the oral session titled “MALDI-TOF Prediction Model Based on a Machine Learning Algorithm for the Detection of ST23 High-Virulence K. pneumoniae”, as part of the session “AI Tools Empowering AMR Prediction in WGS and MALDI-TOF.”
🔹 Our CEO, Luis Mancera Pascual, introduced Clover Biosoft🍀 and showcased our commitment to cutting-edge AI-driven innovation at the Pipeline Corner within the Diagnostic Microbiology section
Sep 2024
Partnership agreement with Progenesis
July 2024
MALDIBANK Project Approved
Clover Bioanalytical Software, as a partner of MIRRIR, has been granted approval for the MALDIBANK Project.
Apr 2024
34th ECCMID Attendance
Presentation of two oral communication from MICROSPEC research group and one poster, all of these project using Clover MSDAS platform.
– Addressing Batch Effect in MALDI-TOF Spectra for Microorganism Classification
– Application of MALDI-TOF mass spectrometry and machine learning for the detection of vancomycin-resistant Enterococcus faecium
– Detection of carbapenemase-producing Klebsiella pneumoniae using MALDI-TOF mass spectrometry and application of machine learning models
Mar 2024
Distribution partnership with Filgen, Inc.
Clover Bioanalytical Software services and products are now available in the Japanese market.
Jan 2024
APTE TOP 100 STARTUPS 2023
Clover Bioanalytical Software is selected as one of the 100 best startups in Spain.
Nov 2023
Funds Granted in National Research and Innovation Planning Funding through NextGenerationEU
Project: Development of new tools for prevention and diagnostics of antibiotic-resistant infections caused by klebsiella pneumoniae.
Oct 2023
Public Founds Raised
Sep 2023
First cut-off for EIC Accelerator Programme passed
Jun 2023
XXVI SEIMC Attendance
Assistance to SEIMC in June 2023 in Santiago de Compostela. Presentation of 3 oral communication.
Jun 2023
Clover Garden Repository released
A Clover Biosoft dedicated repository for MALDI-ToF and FTIR data.
Apr 2023
33nd ECCMID Attendance
Assistance to ECCMID in April 2022.
Apr 2023
Book chapter publication
“Machine Learning in Analysis of Complex Flora Using Mass Spectrometry” Chapter.
Sep 2022
Clover Biosoft is chosen as one of the companies to be part of “Attract2Invest” program of EITHealth
June 2022
Clover Biosoft is selected to participate in the 2nd AcexHealth edition
June 2022
XXV SEIMC Attendance
Assistance to SEIMC in June 2022.
May 2022
Clover Biosoft has joined Beam Alliance as an Associated Member
Apr 2022
32nd ECCMID Attendance
Assistance to ECCMID in April 2022.
Dec 2021
Start of Licensing Agreements
First licensing agreements.
Oct 2021
Clover platform reaches more than 40 institutions from 23 countries
June 2021
Accepted publications related with Clover MS Data Analysis software
https://doi.org/10.1016/j.cmi.2021.06.005
https://doi.org/10.1128/JCM.00800-21
https://doi.org/10.1128/JCM.00238-21
Sep 2020
University of Porto Research Collaboration Relationship
May 2020
Hospital Universitario Virgen del Rocío Research Collaboration Relationship
Apr 2020
Clover Biosoft join to AMR Insights
Luis Mancera Pascual as CEO and Co-Founder of Clover Bioanalytical Software becomes part of AMR Insights Ambassadors.
Aug 2019
Ascend Diagnostics Business Relationship
May 2019
Participation at DES2019
Our CEO and Founder talking about Clover, the current situation of the worldwide problem of resistant infections and how our software can quickly identify resistant strains.
Apr 2019
29th ECCMID Attendance
Feb 2019
EU H2020 SME Instrument Funding
Awarded Seal of Excellence by the European Comission.
Dec 2018
Aug 2018
Selected for the Minerva mentoring program
Apr 2018
28th ECCMID Attendance
Oral communication: Metrological characterization of the reproducibility of MALDI-TOF MS for bacterial strain typing
2018
Complejo Hospitalario Universitario de A Coruña Research Collaboration Relationship
2018
Hospital General Universitario Gregorio Marañón Research Collaboration Relationship
2018
EU H2020 Funding
Clover receives funding from the European Union’s Horizon 2020 research and innovation programme.
2017
Selected for the 2017 Torres Quevedo R&D state program
Clover receives funding from Torres Quevedo programme.
Jan 2016
Business Relationship with Shimadzu
2016
Royal Free Hospital Research Collaboration Relationship
2016
University of Marseille Research Collaboration Relationship
2016
University of Vienna Research Collaboration Relationship
Dec 2015
